Loading insider details...
Beta
Latest Form 4 (Oct 25, 2025): Sale of 47,768 KALA shares, $39.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 25, 2025 | KALA BIO, Inc. (KALA) | Sale | 47,768 | $39.6K |
| Sep 2, 2025 | KALA BIO, Inc. (KALA) | Grant/Award | 180,000 | n/a |
| Jun 27, 2025 | KALA BIO, Inc. (KALA) | Sale | 4,058 | $16.3K |
| Jun 5, 2025 | KALA BIO, Inc. (KALA) | Sale | 3,390 | $12.7K |
| Mar 11, 2025 | KALA BIO, Inc. (KALA) | Grant/Award | 45,200 | n/a |
| Jan 8, 2025 | KALA BIO, Inc. (KALA) | Grant/Award | 10,100 | n/a |
| Jun 28, 2024 | KALA BIO, Inc. (KALA) | Sale | 4,653 | $22.1K |
| Jun 4, 2024 | KALA BIO, Inc. (KALA) | Sale | 2,093 | $12.7K |
| Jan 5, 2024 | KALA BIO, Inc. (KALA) | Grant/Award | 6,500 | n/a |
| Jun 24, 2023 | Kala Pharmaceuticals, Inc. (KALA) | Grant/Award | 48,698 | n/a |